The 12 closest competitors and alternatives to Atley Solutions among biotechnology companies — ranked by similarity to what Atley Solutions actually does, not by market-cap band.
Subscribe to see Atley Solutions’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Atley Solutions is a global leader in commercial products and services for astatine-related (At-211) radiopharmaceutical development and scalable manufacturing, originating from research at the University of Gothenburg.
Atley Solutions is a biotechnology company headquartered in Sweden. Its most recent funding round raised $5M in June 2025. Xcout tracks 7 named people at Atley Solutions, including Milton Lönnroth (CEO).
1 more named person on record for Atley Solutions, with roles, board committees and tenure — see the full roster →
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| — | $5M | 6 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Ranked by semantic similarity — how close each company is to Atley Solutions by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Biotech
AdvanCell Isotopes Pty Ltd is an Australian medical-isotope company developing technologies to produce isotopes used in targeted radiopharmaceutical cancer treatments. It serves radiopharmaceutical developers, pharmaceutical companies, and nuclear-medicine providers seeking reliable supplies of therapeutic isotopes.
Biotech (Enzymes for Biologics)
Genovis is a Swedish biotechnology company that develops and commercializes enzymes and enzyme-based technologies used in the development, characterization, and quality control of biopharmaceuticals. Its customers include pharmaceutical and biotechnology companies, as well as research and analytical laboratories.
Biotech
Navigo Proteins GmbH is a biotechnology research company headquartered in Halle, Germany, specializing in precision protein engineering for life sciences. The firm develops engineered affinity proteins and tailored solutions for biopharmaceutical applications.
Pharmaceuticals
Thor Medical produces and supplies alpha-particle emitters used in targeted cancer therapy and radionuclide treatments. The company utilizes a proprietary, environmentally friendly technology to extract radioactive decay products from thorium for medical applications.
HealthTech
Atelerix is a biotechnology research company based in Newcastle upon Tyne, United Kingdom, that develops innovative cell and tissue preservation technologies using hydrogel technology for ambient temperature storage.
Similar biotechnology company
ITM Isotope Technologies Munich SE develops and supplies targeted radiopharmaceuticals, including diagnostics and therapeutics, for cancer care. The company focuses on precision oncology treatments such as radioligand therapies for hard-to-treat tumors and produces medical radioisotopes like Lutetium-177 and Actinium-225 to serve patients globally.
Similar biotechnology company
Actithera, Inc. is a biotechnology company based in Cambridge, Massachusetts, focused on delivering targeted radioligand cancer therapies.
Biotech
Alpha-9 Oncology is a clinical-stage radiopharmaceutical company that develops targeted, bespoke molecules using peptide engineering and iterative design to treat cancer patients with precision. The company advances a portfolio of radiotherapeutics utilizing optimized binders, linkers, chelators, and radioisotopes for solid tumors.
Biotech
Radiopharm Theranostics Limited, an Australian company established in Carlton in 2021, specializes in the research and development of cutting-edge radiopharmaceutical treatments. Their mission is to address critical gaps in healthcare by creating products for both diagnostic imaging and therapeutic intervention across a spectrum of challenging medical conditions. The company's diverse pipeline features: RAD 204, designed to target PD-L1 for non-small cell lung cancer; RAD 202, aimed at HER2 for breast cancer and other solid tumor types; and two avß6 integrin-targeting agents, RAD 301 (a diagnostic tool for pancreatic ductal adenocarcinoma) and RAD 302 (a therapeutic agent for various cancers). Other significant developments include RAD 101 and RAD 102 for brain metastases, RAD 402 for advanced prostate cancer, and RV01 for multiple solid tumors. To accelerate the clinical progression of its radiopharmaceutical assets, Radiopharm Theranostics maintains a strategic partnership with Lantheus Holdings, Inc.
Similar biotechnology company
Full-Life Technologies Limited is a fully integrated global radiopharmaceutical company focused on drug development in oncology, headquartered in Shanghai, China, with additional operations in Europe.
Similar biotechnology company
Nuclidium is a precision oncology company headquartered in Basel, Switzerland. It specializes in developing next-generation copper radiotheranostics to provide personalized treatment options for cancer patients at various stages.
Biotech
Ratio Therapeutics is a clinical-stage pharmaceutical company headquartered in Boston, Massachusetts. The company employs a suite of innovative technologies for the discovery and early clinical development of targeted radiopharmaceuticals.
Search any company we track to see its competitive set.
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
Funding, investors, tech stack, hiring signals, leadership and corporate events — for Atley Solutionsand every competitor above — in one live dashboard.
Subscribe to Xcout Intel →